Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by HOWARD, W. B.
Right arrow Articles by SHARMA, R. P
Right arrow Search for Related Content
PubMed
Right arrow Articles by HOWARD, W. B.
Right arrow Articles by SHARMA, R. P
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 Oxford University Press

research-article

Pharmacokinetics, Tissue Distribution, and Placental Permeability of All-trans- and 13-cis-N-Ethyl Retinamides in Pregnant Hamsters

W. BRIAN HOWARD*,1, CALVIN C WILLHITE{dagger}, STANLEY T OMAYE{ddagger} and R. P SHARMA*,2

*Toxicology Program, Department ofAnimal, Dairy and Veterinary Sciences, UMC 5600, Utah State University Logan, Utah 84322; {dagger}Department of Health Services State of California; 5850 Shellmound, Emeryville, California 94608 {ddagger}Division of Toxicology, Letterman Army Institute of Research Presidio of San Francisco, California 94129

Received July 21, 1988; accepted November 21, 1988

Pharmacokinetics, Tissue Distribution, and Placental Permeability of All-trans- and 13-cis-N-Ethyl Retinamides in Pregnant Hamsters. HOWARD, W. B., WILLHITE, C. C., OMAYE, S. T., AND SHARMA, R. P. (1989). Fundam. Appl. Toxicol. 12, 621–627. Retinamides have clinical applications in therapy of dermatologic disease, have cancer chemopreventive/chemotherapeutic activities, and possess larger therapeutic ratios than their acidic congeners. The N-ethyl-all-trans-retinamide (NERA) and its 13-cis congener (CNERA) failed to induce terata in hamsters, but an equivalent oral dose of all -trans- or 13-cis-retinoic acid was associated with a significant teratogenic response. Following intubation of 11.4 mg/kg of [3H]NERA or[3H]CNERA to pregnant hamsters during a sensitive stage of development, radioactivity accumulated in maternal bladder and liver. Although plasma concentrations of the parent retinamides declined to nondetectable levels within 12 hr of dosing, near-peak concentrations of retinamide metabolites per sisted in maternal plasma until termination of the study (96 hr). Cis/trans isomerization of each retinamide at Cl3 occurred, but only 15–20% of the total dose could be accounted for as parent retinamide and its Cl3 isomer. The retinamides were not metabolized to detectable concentrations of circulating all-trans- or 13-cis-retinoic acid. Although the label associated with the retinamides and their biotransformation products crossed the placenta, there was no evidence for preferential accumulation in embryonic or fetal tissues. The results presented here show that the reduced teratogenic potency of retinamides compared to acidic retinoids cannot be ascribed to reduced placental transfer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.